1.
J Neuroophthalmol
; 44(1): e153-e154, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38366544
2.
3.
Am J Med
; 136(12): 1216-1221, 2023 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37633407
4.
Open Forum Infect Dis
; 9(7): ofac238, 2022 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35854994
RESUMEN
Nirmatrelvir/ritonavir was recently granted emergency use authorization for mild to moderate coronavirus disease 2019. Drug-drug interactions between ritonavir and tacrolimus are underappreciated by nontransplant providers. We describe 2 solid organ transplant recipients prescribed nirmatrelvir/ritonavir for outpatient use who developed tacrolimus toxicity requiring hospitalization and were managed with rifampin for toxicity reversal.